BMO raises Celanese stock price target to $58 on cost cuts
BMO Capital increased its price target for Celanese (NYSE:CE) to $58 from $56, citing cost-cutting and cash generation. The firm expects higher estimates for 2027-2028 due to growth in engineered materials, despite challenges in the acetyl chain business. Celanese reported Q3 2026 earnings of $1.65 per share, beating estimates, but revenue fell short. Other analysts have also raised price targets.
How this was made
The 30-second read
Why it matters
Analyst upgrades suggest near‑term upside, but supply constraints could limit long‑term gains.
Market read
The upgrade adds fresh positive bias to CE, likely prompting short‑term buying.
What to watch
Potential headwinds from acetyl chain supply issues in 2027‑2028.
Background
Celanese reported mixed Q3 2026 results with earnings beat but revenue miss; analysts are revising outlooks.
Ticker impact
BMO raised its price target on Celanese to $58, citing cost cuts and higher earnings estimates.
upward pressure as investors price in the higher target
The new target and bullish commentary provide fresh upside catalyst.
Market effects
Positive for engineered materials and specialty chemicals sector.
Limited to US-listed chemical stocks.
Modest, reflects broader cost‑cutting trends.
Counterpoint
Target may be overly optimistic if cost cuts underdeliver.
Key entities
- companyCelanese Corp.
US‑listed chemical manufacturer (NYSE:CE).
- analystBMO Capital Markets
Raised price target to $58.


